First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors

Conditions

• Esophageal Squamous Cell Carcinoma
• Gastric Adenocarcinoma
• Gastric Squamous Cell Carcinoma
• Gastroesophageal Junction (GEJ) Adenocarcinoma
• Metastatic Solid Tumor
• Non-Small Cell Lung Carcinoma
• Esophageal Adenocarcinoma
• SMARCA4 Mutation
• Gastroesophageal Junction Squamous Cell Carcinoma
• Advanced Solid Tumor

Interventions

• DRUG: PLX-61639

Sponsor

Plexium, Inc.